3 Biotech Stocks to Buy in January
Amgen, Celldex Therapeutics, and Novavax could all outperform in 2018.
Wednesday, January 3, 2018
3 Biotech Stocks to Buy in January
3 Biotech Stocks to Buy in January
Amgen, Celldex Therapeutics, and Novavax could all outperform in 2018.
Related Posts:
Amazon faces EU antitrust probe over use of merchant data: source- Australian property firm LendLease lands $15 billion deal with Google
- Oil prices gain, U.S. crude trails Brent after inventory data
- Big Tech faces more regulation, oversight but no breakup, analyst says
- Crude futures fall after strong build in U.S. oil products stocks
0 comments:
Post a Comment